Basal Cell Carcinoma (BCC) Completed Phase Trials for Vismodegib (DB08828)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

IndicationStatusPhase
DBCOND0040396 (Basal Cell Carcinoma (BCC))CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02674009Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)
NCT02371967A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)